XML 38 R62.htm IDEA: XBRL DOCUMENT v2.4.0.6
SHARE BASED COMPENSATION (Details) (USD $)
4 Months Ended 6 Months Ended 12 Months Ended 12 Months Ended 12 Months Ended
May 08, 2007
Jun. 14, 2012
Jun. 15, 2010
Dec. 31, 2012
Dec. 17, 2009
Dec. 31, 2012
Incentive Stock Options [Member]
Dec. 31, 2011
Incentive Stock Options [Member]
Dec. 31, 2012
Nonstatutory Stock Options [Member]
Dec. 31, 2011
Nonstatutory Stock Options [Member]
Dec. 31, 2012
Stock Options [Member]
Dec. 31, 2011
Stock Options [Member]
Dec. 31, 2012
Restricted Stock [Member]
Dec. 31, 2011
Restricted Stock [Member]
Dec. 31, 2012
Restricted Stock [Member]
Minimum [Member]
Dec. 31, 2012
Restricted Stock [Member]
Maximum [Member]
Dec. 31, 2012
2006 Equity Incentive Plan [Member]
Dec. 31, 2012
2006 Equity Incentive Plan [Member]
Stock Options [Member]
Dec. 31, 2012
2006 Equity Incentive Plan [Member]
Stock Options [Member]
Minimum [Member]
Dec. 31, 2012
2006 Equity Incentive Plan [Member]
Restricted Stock [Member]
Dec. 31, 2012
2006 Equity Incentive Plan [Member]
Restricted Stock [Member]
Minimum [Member]
Dec. 31, 2012
2006 Equity Incentive Plan [Member]
Restricted Stock [Member]
Maximum [Member]
Weighted average assumptions to estimate the fair value of share-based awards [Abstract]                                          
Expected volatility (in hundredths)           0.00% [1],[2] 94.60% [1],[2] 0.00% [1],[3] 0.00% [1],[3]                        
Risk-fee interest rate % (in hundredths)           0.00% [2],[4] 1.93% [2],[4] 0.00% [3],[4] 0.00% [3],[4]                        
Expected term (in years)           0 years [2] 6 years [2] 0 years [3] 0 years [3]                        
Dividend yield (in hundredths)           0.00% [2],[5] 0.00% [2],[5] 0.00% [3],[5] 0.00% [3],[5]                        
Options Granted [Abstract]                                          
Quantity (in shares)           0 [2] 1,334 [2] 0 [3] 0 [3] 0 1,334                    
Weighted average fair value per share (in dollars per share)           $ 0 [2] $ 1.15 [2] $ 0 [3] $ 0 [3]                        
Fair value           $ 0 [2] $ 1,534 [2] $ 0 [3] $ 0 [3]                        
Options, Outstanding [Roll Forward]                                          
Outstanding, beginning of period (in shares)                   287,745 290,411                    
Granted (in shares)           0 [2] 1,334 [2] 0 [3] 0 [3] 0 1,334                    
Forfeited/cancelled (in shares)                   (129,336) (4,000)                    
Exercised (in shares)                   0 0                    
Outstanding, end of period (in shares)                   158,409 287,745                    
Outstanding, Weighted Average Exercise Price [Roll Forward]                                          
Outstanding, beginning of period (in dollars per share)                   $ 16.89 $ 16.76                    
Granted (in dollars per share)                   $ 0 $ 1.50                    
Forfeited/cancelled (in dollars per share)                   $ 22.49 $ 2.40                    
Exercised (in dollars per share)                   $ 0 $ 0                    
Outstanding, end of period (in dollars per share)                   $ 12.32 $ 16.89                    
Nonvested restricted stock awards, Number of Shares [Roll Forward]                                          
Outstanding, beginning of period (in shares)                       1,096 6,336                
Granted (in shares)                       0 0                
Forfeited/cancelled (in shares)                       (97) 0                
Exercised/issued (in shares)                       (699) (5,240)                
Outstanding, end of period (in shares)                       300 1,096                
Nonvested restricted stock awards, Weighted Average Grant Date Fair Value [Roll Forward]                                          
Outstanding, beginning of period (in dollars per share)                       $ 41.47 $ 14.23                
Granted (in dollars per share)                       $ 0 $ 0                
Forfeited/cancelled (in dollars per share)                       $ 34.59 $ 0                
Exercised/issued (in dollars per share)                       $ 45.39 $ 8.53                
Outstanding, end of period (in dollars per share)                       $ 34.59 $ 41.47                
Additional disclosures [Abstract]                                          
Vesting period                           6 months 5 years     1 year   6 months 4 years
Number of shares authorized (in shares)                               133,333          
Number of additional shares authorized (in shares) 266,667 400,000 200,000 1,200,000 200,000                                
Contractual term                             10 years            
Number of options granted to date (in shares)                                 408,667        
Number of restricted shares granted to date (in shares)                                     68,616    
Number of shares available for grant (in shares)                               972,145          
Nonvested Awards, unearned share-based compensation [Abstract]                                          
Unearned share-based compensation expense                   $ 34,169   $ 991                  
Unearned share-based compensation, recognition period                   15 months   3 months                  
[1] Expected volatility assumption was based upon a combination of historical stock price volatility measured on a daily basis and an estimate of expected future stock price volatility.
[2] The Company did not award any incentive stock options for the year ended December 31, 2012.
[3] The Company did not award any nonstatutory stock options for the years ended December 31, 2012 and 2011, respectively.
[4] Risk-free interest rate assumption is based upon U.S. Treasury bond interest rates appropriate for the term of the stock options.
[5] The Company does not currently intend to pay cash dividends, thus has assumed a 0% dividend yield.